PBK and Familial prostate cancer: Together, we provide evidence that PBK/TOPK, by induction of a pro-metastatic gene expression program in prostate cancer cells, triggers aggressive behavior and we propose evaluation of PBK/TOPK as a prognostic marker and therapeutic target in men with aggressive prostate cancer.